Evaluation in 18 patients with polycythemia vera showed hematocrit control below 45%, accompanied by a "dramatic decrease in ...

The phase 2 SANRECO study has recently completed enrollment and will evaluate divesiran, a potential therapy for patients ...

CURE spoke with Dr. Marina Kremyanskaya about the treatment landscape for patients with polycythemia vera.

Silence Therapeutics advanced its RNAi drug for polycythemia vera, shared new Phase 2 trial updates, and reaffirmed a strong ...

Marissa Johanna Maria Traets Bridging Pathophysiology and Therapeutic Targets in Sickle Cell Disease dr. M.A.E. Rab ...

A 15-year-old beauty clinic employee has made shocking allegations about her former workplace, also the subject of a SafeWork NSW investigation, news.com.au can reveal.

DEAR DR. ROACH: My husband was diagnosed with secondary polycythemia in 2011. His hematocrit test (HCT) was 57%. He was referred to a hematologist. The hematologist would order a phlebotomy when his ...

Dear Dr. Roach: My husband was diagnosed with secondary polycythemia in 2011. His hematocrit test (HCT) was 57%. He was referred to a hematologist. The hematologist would order a phlebotomy when his ...

A therapeutic intervention is an effort to help someone in need who declines treatment or is otherwise unable to help themselves. In some cases, an intervention takes the form of a meeting between the ...

Incyte (Nasdaq:INCY) today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual ...